Ariad Pharmaceuticals (ARIA) 8.08 $ARIA Why Ariad

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ariad Pharmaceuticals (ARIA) 8.08 $ARIA

Why Ariad Pharmaceuticals, Inc. Catapulted 26% Higher in February
Sean Williams, The Motley Fool - Motley Fool - Thu Mar 05, 7:02AM CST
What: Shares of Ariad Pharmaceuticals , a biopharmaceutical company primarily focused on discovering therapies to treat cancer, catapulted higher by 26% in February, based on data from S&P Capital IQ , following the release of its...
ARIA: 8.08 (-0.17)

Early Briefing on Biotech Industry Stocks -- ARIAD Pharma, Array BioPharma, Rexahn Pharma, Inotek Pharma, and Neurocrine Biosciences
PR Newswire - Tue Mar 03, 7:40AM CST
Editor Note: For more information about this release, please scroll to bottom.
RNN: 0.75 (-0.02), NBIX: 40.67 (-0.25), ITEK: 6.00 (unch), ARIA: 8.08 (-0.17), ARRY: 8.06 (-0.18)

Uptrend Call Working As Ariad Pharmaceuticals Stock Rises 12.2% (ARIA)
Comtex SmarTrend(R) - Mon Mar 02, 9:55AM CST
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on December 22nd, 2014 at $7.12. In approximately 2 months, Ariad Pharmaceuticals has returned 12.22% as of today's recent price of $7.99.
ARIA: 8.08 (-0.17)

Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CYTK: 7.80 (-0.11), VRX: 198.71 (-5.24), ACT: 289.92 (-5.78), PCYC: 254.56 (+0.34), MDT: 76.48 (-2.02), CAH: 87.01 (-1.94), CLDX: 29.39 (-0.39), HSP: 87.90 (+0.05), AGN: 233.51 (-1.90), JNJ: 100.11 (-2.41), ATOS: 1.97 (-0.04), ONVO: 5.59 (-0.13), PTCT: 71.13 (-1.59), SNY: 47.42 (-0.94), PTLA: 41.72 (-0.13), INCY: 90.00 (-1.97), PFE: 33.97 (-0.50), CPHR: 11.67 (-0.33), MYL: 55.44 (-1.25), AMGN: 154.88 (-4.72), LLY: 68.41 (-2.18), BMY: 65.12 (-0.93), MNKD: 5.47 (-0.26), NKTR: 13.02 (-0.28), OMER: 26.14 (-0.21), DVA: 77.63 (+0.70), GILD: 101.81 (-1.61), SGEN: 35.32 (-0.28), ACHN: 11.39 (+0.40), MRK: 56.84 (-1.14), TEVA: 56.40 (-0.11), BIL: 45.72 (-0.01), ARIA: 8.08 (-0.17), NVS: 97.46 (-1.49)

What Sarissa Capital's Proxy Fight Means For Ariad Investors
Investing Healthcare - at Seeking Alpha - Mon Feb 23, 7:53AM CST

AMRN: 1.78 (+0.11), VVUS: 2.79 (-0.08), ARIA: 8.08 (-0.17)

Nasdaq stocks posting largest percentage increases
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
PATK: 56.16 (-0.68), TILE: 19.90 (-0.24), DISCB: 33.59 (-1.31), DISCA: 33.08 (-0.48), CCRN: 11.01 (+0.05), EGLT: 14.05 (-1.13), DISCK: 31.77 (-0.38), PRQR: 22.86 (+1.49), AMOT: 25.23 (-1.66), ATRO: 69.15 (-2.21), ASMB: 14.41 (-0.22), ARIA: 8.08 (-0.17), UNTD: 17.02 (-0.72), WSCI: 6.12 (-0.01), SZMK: 7.75 (-0.47)

Most active Nasdaq-traded stocks
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 28.50 (-0.78), FB: 80.00 (-1.21), DISCB: 33.59 (-1.31), DISCA: 33.08 (-0.48), INTC: 33.19 (-0.54), DISCK: 31.77 (-0.38), MRVL: 16.56 (+0.05), AMAT: 23.91 (-0.27), ODP: 9.30 (-0.04), ARIA: 8.08 (-0.17), MSFT: 42.36 (-0.75), ZNGA: 2.54 (+0.13), AAPL: 126.60 (+0.19), CSCO: 28.92 (-0.38)

Arista and Noodles are big market movers
AP - Fri Feb 20, 4:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
FUEL: 10.34 (+0.02), NDLS: 17.49 (-0.58), ARIA: 8.08 (-0.17)

Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), CVM: 1.06 (-0.08), MDGN: 8.35 (+0.17), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), RPRX: 9.84 (-0.01), MNKD: 5.47 (-0.26), CELG: 118.03 (-2.68), SGEN: 35.32 (-0.28), TEVA: 56.40 (-0.11), ARIA: 8.08 (-0.17), SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)

Why Ariad Pharmaceuticals, Inc. Stock Soared Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 20, 2:38PM CST
Although we don't believe in   timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: After reporting fourth quarter and full...
ARIA: 8.08 (-0.17)

Ariad's largest shareholder starts proxy fight to oust CEO
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 9:12AM CST

VVUS: 2.79 (-0.08), ARIA: 8.08 (-0.17)

Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger
at The Street - Fri Feb 20, 6:09AM CST
Activist hedge fund Sarissa Capital is starting a proxy fight to force the ouster of Ariad Pharmaceuticals founder and CEO Harvey Berger.
ARIA: 8.08 (-0.17)

ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 19, 1:41PM CST

ARIA: 8.08 (-0.17)

Ariad Pharmaceuticals ups revenues 695% in Q4
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 8:22AM CST

ARIA: 8.08 (-0.17)

ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 8:05AM CST
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss
ARIA: 8.08 (-0.17)

Ariad reports 4Q loss
Automated Insights - Thu Feb 19, 7:43AM CST
CAMBRIDGE, Mass. (AP) _ Ariad Pharmaceuticals Inc. (ARIA) on Thursday reported a loss of $5.8 million in its fourth quarter.
ARIA: 8.08 (-0.17)

ARIAD Pharmaceuticals (ARIA) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 19, 7:25AM CST

ARIA: 8.08 (-0.17)

ARIAD Pharmaceuticals beats by $0.17, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 6:39AM CST

ARIA: 8.08 (-0.17)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 100

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 154

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 65

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
ISC2 Launches AI Security Academy for Cyber Pros

Updated Category News Views 22

AI-Driven Threats Demand Expert Attention Every corner of the tech world has been blabbering about AI, but when it comes to cybersecurity, it's a whole different beast entirely. ISC2—a nonprofit that I like to think of as the cyber wizards’ guild—just threw a lifeline to cybersecurity folks who are swimming in the deep end of AI. With their shiny new AI Security...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Flexible Packaging Market to Hit $384.32B by 2031

Updated Category News Views 17

Packaging's Flexible Future Alright, here's the skinny: you might want to adjust those portfolios if you're watching the materials sector, because the flexible packaging market ain't just loosening up—it's stretching out like never before. By 2031, we're talking about it raking in a solid $384.32 billion, climbing from $313.25 billion in 2026. That's a not-so-shabby...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 146

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 87

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 145

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 101

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading

Top 5 Most Recently Viewed Articles

Volta Finance Limited: Monthly Insights and Performance Metrics

Updated Category News Views 252

Understanding Volta Finance Limited's Performance for September 2025 Volta Finance Limited (VTA / VTAS) recently released its monthly report for September 2025. This report sheds light on the performance metrics that have shaped the company's strategies and outcomes over the past month, illustrating how they navigate an ever-changing financial landscape. Performance...

Continue Reading
Class Actions Alert: Understanding Investor Rights for SOC, LMT, NVO, LINE

Updated Category News Views 213

Understanding Class Action Lawsuits for Shareholders In today’s fast-paced investment world, shareholders must stay informed about class action lawsuits that may affect their investments. A recent alert highlights key class actions involving four publicly-traded companies, offering investors a glimpse into their rights and potential next steps. Sable Offshore Corp....

Continue Reading
Exploring ONCT-534: New Insights on Advanced Prostate Cancer

Updated Category News Views 202

Recent Updates on ONCT-534 for Advanced Prostate Cancer Oncternal Therapeutics, Inc. (NASDAQ: ONCT) has unveiled encouraging updates regarding its investigational therapy, ONCT-534, specifically targeting relapsed or refractory metastatic Castration-Resistant Prostate Cancer (mCRPC). This exciting development stems from the company’s ongoing Phase 1/2 Study, known as...

Continue Reading
GDS Holdings Celebrates Successful IPO of C-REIT in Shanghai

Updated Category News Views 197

GDS Holdings Completes C-REIT IPO on Shanghai Stock Exchange Shanghai, China — GDS Holdings Limited (NASDAQ: GDS; HKEX: 9698), a prominent developer and operator of high-performance data centers, has recently triumphantly finished its initial public offering (IPO) for the China REIT (C-REIT) on the Shanghai Stock Exchange. This achievement marks a significant milestone...

Continue Reading
Surge in Russian Stocks: MOEX Russia Index Reaches New Heights

Updated Category News Views 255

Russian Stocks Experience Notable Gains In recent trading sessions, Russian stocks showed significant upward movement, showcasing the resilience of various sectors within the economy. With the MOEX Russia Index closing higher, this is an indication of investor optimism and market recovery. Key Contributors to Market Gains Sector Performance Highlights The increase in the...

Continue Reading